vs
Side-by-side financial comparison of Eastern Bankshares, Inc. (EBC) and TANDEM DIABETES CARE INC (TNDM). Click either name above to swap in a different company.
Eastern Bankshares, Inc. is the larger business by last-quarter revenue ($295.9M vs $247.2M, roughly 1.2× TANDEM DIABETES CARE INC). Eastern Bankshares, Inc. runs the higher net margin — 22.1% vs -8.2%, a 30.3% gap on every dollar of revenue. On growth, Eastern Bankshares, Inc. posted the faster year-over-year revenue change (710.6% vs 5.5%). Over the past eight quarters, Eastern Bankshares, Inc.'s revenue compounded faster (38.6% CAGR vs 5.5%).
Eastern Bank is a bank based in Boston, Massachusetts. Before de-mutualizing in 2020, it was the oldest and largest mutual bank in the United States and the largest community bank in Massachusetts.
Tandem Diabetes Care, Inc. is an American medical device manufacturer based in San Diego, California. The company develops medical technologies for the treatment of diabetes and specifically insulin infusion therapy.
EBC vs TNDM — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $295.9M | $247.2M |
| Net Profit | $65.3M | $-20.4M |
| Gross Margin | — | 55.3% |
| Operating Margin | — | 37.6% |
| Net Margin | 22.1% | -8.2% |
| Revenue YoY | 710.6% | 5.5% |
| Net Profit YoY | -34.4% | — |
| EPS (diluted) | $0.29 | $-0.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $295.9M | $247.2M | ||
| Q4 25 | $37.5M | $290.4M | ||
| Q3 25 | $241.5M | $249.3M | ||
| Q2 25 | $244.9M | $240.7M | ||
| Q1 25 | $31.1M | $234.4M | ||
| Q4 24 | $216.5M | $282.6M | ||
| Q3 24 | $203.4M | $244.0M | ||
| Q2 24 | $154.0M | $221.9M |
| Q1 26 | $65.3M | $-20.4M | ||
| Q4 25 | $99.5M | $-589.0K | ||
| Q3 25 | $106.1M | $-21.2M | ||
| Q2 25 | $100.2M | $-52.4M | ||
| Q1 25 | $-217.7M | $-130.6M | ||
| Q4 24 | $60.8M | $755.0K | ||
| Q3 24 | $-6.2M | $-23.3M | ||
| Q2 24 | $26.3M | $-30.8M |
| Q1 26 | — | 55.3% | ||
| Q4 25 | — | 57.7% | ||
| Q3 25 | — | 53.9% | ||
| Q2 25 | — | 52.3% | ||
| Q1 25 | — | 50.5% | ||
| Q4 24 | — | 55.7% | ||
| Q3 24 | — | 51.1% | ||
| Q2 24 | — | 50.8% |
| Q1 26 | — | 37.6% | ||
| Q4 25 | — | 2.9% | ||
| Q3 25 | 38.9% | -9.2% | ||
| Q2 25 | 41.0% | -21.5% | ||
| Q1 25 | -590.9% | -51.6% | ||
| Q4 24 | 33.3% | -0.2% | ||
| Q3 24 | -1.6% | -10.7% | ||
| Q2 24 | 24.7% | -13.9% |
| Q1 26 | 22.1% | -8.2% | ||
| Q4 25 | 265.6% | -0.2% | ||
| Q3 25 | 44.0% | -8.5% | ||
| Q2 25 | 40.9% | -21.8% | ||
| Q1 25 | -699.2% | -55.7% | ||
| Q4 24 | 28.1% | 0.3% | ||
| Q3 24 | -3.0% | -9.5% | ||
| Q2 24 | 17.1% | -13.9% |
| Q1 26 | $0.29 | $-0.30 | ||
| Q4 25 | $0.48 | $0.02 | ||
| Q3 25 | $0.53 | $-0.31 | ||
| Q2 25 | $0.50 | $-0.78 | ||
| Q1 25 | $-1.08 | $-1.97 | ||
| Q4 24 | $0.29 | $0.00 | ||
| Q3 24 | $-0.03 | $-0.35 | ||
| Q2 24 | $0.16 | $-0.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $551.7M | $570.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $4.3B | $132.4M |
| Total Assets | $30.6B | $1.2B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $551.7M | $570.3M | ||
| Q4 25 | $507.6M | $292.7M | ||
| Q3 25 | $703.4M | $319.1M | ||
| Q2 25 | $948.3M | $315.4M | ||
| Q1 25 | $609.0M | $368.6M | ||
| Q4 24 | $1.9B | $438.3M | ||
| Q3 24 | $1.7B | $473.3M | ||
| Q2 24 | $1.4B | $452.4M |
| Q1 26 | $4.3B | $132.4M | ||
| Q4 25 | $4.3B | $155.2M | ||
| Q3 25 | $3.8B | $133.0M | ||
| Q2 25 | $3.7B | $133.3M | ||
| Q1 25 | $3.6B | $155.3M | ||
| Q4 24 | $3.6B | $263.1M | ||
| Q3 24 | $3.7B | $237.7M | ||
| Q2 24 | $3.0B | $233.9M |
| Q1 26 | $30.6B | $1.2B | ||
| Q4 25 | $30.6B | $881.1M | ||
| Q3 25 | $25.5B | $874.7M | ||
| Q2 25 | $25.5B | $875.7M | ||
| Q1 25 | $25.0B | $922.1M | ||
| Q4 24 | $25.6B | $967.7M | ||
| Q3 24 | $25.5B | $957.7M | ||
| Q2 24 | $21.0B | $937.5M |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
